Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Item
http://www.wikidata.org/entity/Q38194531
Bile Acids in Neurodegenerative DisordersIntranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsGene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN DeficiencyProtection of Cultured Dopamine Neurons from MPP(+) Requires a Combination of Neurotrophic Factors.An update on potential therapeutic strategies for Parkinson's disease based on pathogenic mechanisms.Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease.Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.Brain-derived neurotrophic factor mediates neuroprotection against Aβ-induced toxicity through a mechanism independent on adenosine 2A receptor activation.Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.
P2860

Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Item
http://www.wikidata.org/entity/Q38194531
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges and promises in the ...... apies for Parkinson's disease.
@en
type
label
Challenges and promises in the ...... apies for Parkinson's disease.
@en
prefLabel
Challenges and promises in the ...... apies for Parkinson's disease.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Challenges and promises in the ...... rapies for Parkinson's disease
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698